HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.

Please see our Editorial and Fact-Checking Policy for more detail.

HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.

FRIDAY, Sept. 9, 2022 (HealthDay News) -- Lung cancer CT screening scans can catch tumors at an earlier and more treatable stage, a new study indicates.

The number of stage 1 lung cancers detected by doctors increased 8.4% after low-dose CT screening scans were implemented across four different health care systems, according to findings published recently in the Journal of Thoracic Oncology.

Regular lung cancer screenings also were linked to a 6.6% decrease in stage 4 cancers, because the tumors were caught earlier, researchers said.

The statistics were drawn from four major health systems that are part of a consortium aimed at optimizing lung cancer screenings -- Henry Ford Health System in Detroit, Kaiser Permanente Colorado, Kaiser Permanente Hawaii and the University of Pennsylvania Health System.

Researchers looked at nearly 3,700 patients diagnosed with lung cancer at the four systems between January 2014 and September 2019, looking specifically at how advanced the cancers were when discovered.

By the end of the study, CT scan screens were catching about 20% of the lung cancer cases diagnosed at the centers, said researchers led by Dr. Anil Vachani, from the University of Pennsylvania.

In addition, the number of early-stage tumors had increased while the number of late-stage tumors had declined – showing that doctors were catching lung cancer when patients still had the best chance of survival.

This also showed that the screening did not result in over-diagnosis, which can cause patients to undergo unnecessary biopsies and other follow-up testing, the researchers said in a journal news release.

The American Cancer Society has more about lung cancer screening.

SOURCE: Journal of Thoracic Oncology, news release, Sept. 7, 2022

This story may be outdated. We suggest some alternatives.

The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at solutions@healthday.com with any questions.

By Dennis Thompson HealthDay Reporter

This website is certified by Health On the Net Foundation. Click to verify.